103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
Introduced 2/6/2023, by Sen. Celina Villanueva
SYNOPSIS AS INTRODUCED:
Amends the Illinois Insurance Code. Provides that an individual or
group policy of accident and health insurance amended, delivered, issued,
or renewed in the State on or after (rather than only after) January 1,
2024 shall provide coverage for all abortifacients, hormonal therapy
medication, human immunodeficiency virus pre-exposure prophylaxis and
post-exposure prophylaxis drugs approved by the United States Food and
Drug Administration, and follow-up services related to that coverage.
A BILL FOR
|SB1344||LRB103 28584 LNS 54965 b|
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
The Illinois Insurance Code is amended by
changing Section 356z.60 as follows:
(215 ILCS 5/356z.60)
Coverage for abortifacients, hormonal
therapy, and human immunodeficiency virus pre-exposure
prophylaxis and post-exposure prophylaxis.
(a) As used in this Section:
"Abortifacients" means any medication administered to
terminate a pregnancy by a health care professional.
"Health care professional" means a physician licensed to
practice medicine in all of its branches, licensed advanced
practice registered nurse, or physician assistant.
"Hormonal therapy medication" means hormonal treatment
administered to treat gender dysphoria.
"Therapeutic equivalent version" means drugs, devices, or
products that can be expected to have the same clinical effect
and safety profile when administered to patients under the
conditions specified in the labeling and that satisfy the
following general criteria:
(1) it is approved as safe and effective;